ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,656Medicare Part D Prescriptions Filled, Including Refills

Rank: 147 out of 670

$610K Total Retail Price of All Prescriptions

Rank: 133 out of 670

458 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 6,085 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 489 212 S3 1 1
OMEPRAZOLE 332 198 2 5
FUROSEMIDE 304 211 3 6
SIMVASTATIN 230 185 4 4
LEVOTHYROXINE SODIUM 215 152 5 2
LISINOPRIL 195 152 6 3
METOPROLOL TARTRATE 185 110 7 9
METFORMIN HCL 184 99 8 8
NEXIUM 148 106 9 14
GLIMEPIRIDE 130 103 10 32
WARFARIN SODIUM 129 112 11 13
CITALOPRAM HBR 120 102 12 20
AMLODIPINE BESYLATE 119 90 13 7
AMITRIPTYLINE HCL 109 59 R 14 68
POTASSIUM CHLORIDE 109 60 14 16
CLOPIDOGREL 100 60 16 24
ZOLPIDEM TARTRATE 97 70 17 23
GABAPENTIN 94 46 18 11
TRAMADOL HCL 91 40 19 21
PROAIR HFA 90 54 20 28
RANITIDINE HCL 88 61 21 25
CRESTOR 86 33 22 18
ESCITALOPRAM OXALATE 82 49 23 78
MELOXICAM 80 72 24 33
DIGOXIN 77 62 25 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 62 26 27
TIZANIDINE HCL 75 0 26 87
TAMSULOSIN HCL 75 69 26 30
HYDROCHLOROTHIAZIDE 74 54 29 10
PREDNISONE 74 65 29 40
METOPROLOL SUCCINATE 73 46 31 12
FAMOTIDINE 73 46 31 99
SPIRIVA 72 61 33 51
CYMBALTA 72 21 33 36
LANTUS 67 37 35 58
ATORVASTATIN CALCIUM 67 44 35 15
ATENOLOL 64 48 37 17
FLUOXETINE HCL 64 36 37 55
NAPROXEN 63 34 39 81
PLAVIX 63 45 39 34
MIRTAZAPINE 61 46 41 59
ALPRAZOLAM 60 44 42 138
PROPRANOLOL HCL 55 43 43 130
SINGULAIR 55 38 43 56
KLOR-CON M20 54 51 45 57
IBUPROFEN 54 31 45 50
OXYCODONE-ACETAMINOPHEN 54 25 S2 45 77
DEXILANT 54 16 45 70
NITROSTAT 51 40 49 155
DICLOFENAC SODIUM 50 0 50 110
LYRICA 50 23 50 65
TRIAMTERENE-HCTZ 50 40 50 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.